The global head & neck cancer drugs market was valued at $1,295 million in 2017, and is projected to reach $2,281 million by 2025, registering a CAGR of 7.3% from 2018 to 2025.
Report Code : A04812 | Pages : 201 | Category : Life Sciences
The global pneumonia testing market was valued at $1.6 billion in 2020, and is projected to reach $3.0 billion by 2030, growing at a CAGR of 6.5% from 2021 to 2030.
Report Code : A03434 | Pages : 180 | Category : Life Sciences
The global bronchodilators market size was valued at $27,580.00 million in 2018 and is expected to reach $41,487.53 million by 2026, registering a CAGR of 5.2% from 2019 to 2026. Bronchodilators are the drugs that relax muscles that tighten around the airways.
Report Code : A03597 | Pages : 207 | Category : Life Sciences
The global biopharmaceuticals market accounted for $186,470 million in 2017, and is projected to reach $526,008 million by 2025, registering a CAGR of 13.8% from 2018 to 2025. ...
Report Code : A03626 | Pages : 255 | Category : Life Sciences
The chlorpheniramine maleate market was valued at $468.6 million in 2022, and is projected to reach $751.4 million by 2032, growing at a CAGR of 4.9% from 2023 to 2032.
Report Code : A03630 | Pages : 438 | Category : Life Sciences
The Global Gastroparesis Market was valued at $4,667 million in 2016, and is projected to reach $6,486 million at a CAGR of 4.7% from 2017 to 2023. Gastroparesis ...
Report Code : A03806 | Pages : 231 | Category : Life Sciences
The anti-obesity drugs market was valued at $1,605.36 million in 2022 and is estimated to reach $4,439.34 million by 2032, exhibiting a CAGR of 10.7% from 2023 to 2032.
Report Code : A03823 | Pages : 447 | Category : Life Sciences
Cholera vaccine market is projected to reach $207 million by 2025. The U.S. market has the highest share of the market. It is market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Report Code : A04815 | Pages : 149 | Category : Life Sciences
The U.S. topical pain relief market was valued at $2,612 million in 2019, and is projected to reach $3,272 million by 2027 at a CAGR of 3.7% from 2020 to 2027.
Report Code : A04993 | Pages : 128 | Category : Life Sciences
The global legal marijuana market size was valued at $17.5 billion in 2021, and is projected to reach $80.1 billion by 2031, growing at a CAGR of 16.9% from 2022 to 2031.
Report Code : A05149 | Pages : 230 | Category : Life Sciences
The global inflammatory bowel disease drugs market was valued at $21 billion in 2021, and is projected to reach $34.5 billion by 2031, growing at a CAGR of 5.1% from 2022 to 2031.
Report Code : A03971 | Pages : 274 | Category : Life Sciences
The global acne medication market was valued at $13.4 billion in 2023, and is projected to reach $24.2 billion by 2035, growing at a CAGR of 5.1% from 2024 to 2035.
Report Code : A04007 | Pages : 280 | Category : Life Sciences
3D Printed Drugs Market are medications, which are designed by 3D printing technique to customize for the individuals in a safer and effective way. These drugs have unitary ...
Report Code : A04158 | Pages : 125 | Category : Life Sciences
The global Cognitive and Memory Enhancer Drugs Market size was valued at $5,079.86 million in 2020, and is projected to reach $8,689.74 million by 2030, registering a CAGR ...
Report Code : A04205 | Pages : 270 | Category : Life Sciences
The global hormonal contraceptive market was valued at $17.3 billion in 2023, and is projected to reach $26.6 billion by 2035, growing at a CAGR of 3.6% from 2024 to 2035.
Report Code : A04222 | Pages : 348 | Category : Life Sciences
The Japan oncology drugs market size was accounted for $9,405 million in 2018, and is expected to reach $14,109 million by 2026, registering a CAGR of 5.2% from 2019 to 2026.
Report Code : A05277 | Pages : 147 | Category : Life Sciences
The global mental health software market was valued at $4.8 billion in 2023, and is projected to reach $14.6 Billion by 2033, growing at a CAGR of 11.7% from 2024 to 2033
Report Code : A05457 | Pages : 216 | Category : Life Sciences
The global antifibrinolytic drugs market was valued at $13,593 million in 2018 and is expected to reach $19,333 million by 2026, registering a CAGR of 4.5% from 2019 to 2026.
Report Code : A05914 | Pages : 165 | Category : Life Sciences
The global brain health supplements market size was valued at $7,653.4 million in 2020, and is projected to reach $19,730.1 million by 2030, registering a CAGR of 9.9% from 2021 to 2030.
Report Code : A04229 | Pages : 288 | Category : Life Sciences
The Africa large volume parenterals (LVP) market was valued at $662 million in 2017, and is expected to reach $1,133 million by 2024, growing at a CAGR of ...
Report Code : A04260 | Pages : 85 | Category : Life Sciences
The global benign prostatic hyperplasia therapeutics market was valued at was valued at $5,697.70 million in 2020, and is estimated to reach $9,391.50 million by 2030, growing at ...
Report Code : A04353 | Pages : 216 | Category : Life Sciences
The global occupational medicines market was valued at $3,753 million in 2017, and is estimated to reach $5,794 million by 2025, registering a CAGR of 5.5% from 2018 ...
Report Code : A04373 | Pages : 220 | Category : Life Sciences
The global artificial intelligence in medicines market was valued at $719 million in 2017 and is estimated to reach $18,119 million at a CAGR of 49.6% from 2018 ...
Report Code : A04391 | Pages : 231 | Category : Life Sciences
The global alopecia treatment market was valued at $2,736 million in 2018, and is projected to reach $3,935 million by 2026, registering a CAGR of 4.6% from 2019 to 2026.
Report Code : A05945 | Pages : 243 | Category : Life Sciences
The global polycystic ovarian syndrome treatment market size was valued at $2,902 million in 2018, and is projected to reach $4,184 million by 2026, registering a CAGR of 4.7% from 2019 to 2026.
Report Code : A05949 | Pages : 217 | Category : Life Sciences
